Our Company
Presentation
Management Team
Board of directors
Scientific Advisory Board
Contact
Products
Tedopi®
OSE-279
Lusvertikimab (OSE-127)
Pegrizeprument (FR104)
BI 770371
ABBV-230
CLEC-1
Research & Development
Scientific publications
Investors
Press Releases
Regulated information
Financial documents
General Shareholders’ meetings
Partnerships
Pharma partnerships
Clinical partnerships
Academic and public Partnerships
News
Agenda
Press Releases
Contact
en
fr
P
r
o
j
e
c
t
s
A
r
c
h
i
v
e
s
September 2023
CICON23 – International Cancer Immunotherapy Conference
September 2023
European MidCap Event, 23rd Edition
September 2023
H.C. Wainwright 25th Annual Global Investment Conference
September 2023
23RD ANNUAL BIOTECH IN EUROPE FORUM FOR GLOBAL PARTNERING & INVESTMENT
December 2022
Degroof Petercam Healthcare Conference
December 2022
J.P. Morgan Healthcare Conference
November 2022
Invest Securities BioMed Forum
September 2022
HealthTech Innovation Days
September 2022
Amsterdam Midcap Event
September 2022
H.C. Wainwright 24th Annual Global Investment Conference
Précédent
1
2
3
4
5
Suivant